EDAP TMS reported EUR13.88M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AngioDynamics USD 79.43M 3.72M Sep/2025
Boston Scientific USD 5.29B 220M Dec/2025
EDAP TMS EUR 13.88M 2.16M Sep/2025
Henry Schein USD 3.4B 60M Dec/2025
Medtronic USD 9B 39M Jan/2026
Plus Therapeutics USD 1.37M 30K Dec/2025
Veracyte USD 140.6M 8.7M Dec/2025